Bio-Rad Laboratories, Inc.
BIO
株式のランク
#2167
Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules,... Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.
株価
$352.07
最終同期: 2026-10-19
時価総額
$9.41B
変化（1日）
-0.23%
変化（1年）
9.37%
国
US
取引 Bio-Rad Laboratories, Inc. (BIO)
カテゴリー
Healthcare
Bio-Rad Laboratories, Inc.（BIO）の利益
Jun 2026 時点の利益 TTM: $350.40M
Bio-Rad Laboratories, Inc. の最新の財務報告によると、同社の現在の利益は $350.40M です。2024 年には $-2.34B の利益を上げ、これは 2023 年の利益 $-850.10M と 減少 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Bio-Rad Laboratories, Inc. の利益の推移（2000 〜 2026）
各年末の利益
| 年 | 利益 | 変化 |
|---|---|---|
| 2026 (TTM) | $350.40M | -64.80% |
| 2025 | $995.50M | -142.50% |
| 2024 | $-2.34B | 175.55% |
| 2023 | $-850.10M | -81.93% |
| 2022 | $-4.70B | -186.33% |
| 2021 | $5.45B | 10.80% |
| 2020 | $4.92B | 117.51% |
| 2019 | $2.26B | 345.66% |
| 2018 | $507.36M | 418.75% |
| 2017 | $97.81M | 135.33% |
| 2016 | $41.56M | -71.50% |
| 2015 | $145.85M | 10.86% |
| 2014 | $131.56M | 17.06% |
| 2013 | $112.39M | -51.47% |
| 2012 | $231.58M | -1.77% |
| 2011 | $235.76M | 7.03% |
| 2010 | $220.28M | 18.54% |
| 2009 | $185.83M | 30.10% |
| 2008 | $142.84M | 18.21% |
| 2007 | $120.84M | -14.92% |
| 2006 | $142.03M | 52.11% |
| 2005 | $93.37M | -4.06% |
| 2004 | $97.33M | -14.39% |
| 2003 | $113.69M | 8.89% |
| 2002 | $104.41M | 60.70% |
| 2001 | $64.97M | 42.97% |
| 2000 | $45.44M | 0.00% |
同業他社の利益
| 企業 | 利益 | 利益の差 | 国 |
|---|---|---|---|
| $7.51B | 2,043.55% |
US
|
|
| $5.56B | 1,487.61% |
IE
|
|
| $5.15B | 1,369.18% |
US
|
|
| $3.86B | 1,001.88% |
US
|
|
| - | - |
DE
|
